openPR Logo
Press release

Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) over potential Wrongdoing

08-17-2021 03:04 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Shareholders Foundation

An investigation on behalf of current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares.

An investigation on behalf of current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares.

An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of ACADIA Pharmaceuticals Inc..

Investors who are current long term investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554.

The investigation by a law firm for current long term investors in NASDAQ: ACAD stocks follows a lawsuit filed against ACADIA Pharmaceuticals Inc. over alleged securities laws violations. The investigation on behalf of current long term investors in NASDAQ: ACAD stocks, concerns whether certain ACADIA Pharmaceuticals Inc. directors are liable in connection with the allegations made in that lawsuit.

According to that complaint filed in the U.S. District Court for the Southern District of California the plaintiff alleges that the Defendants made false and/or misleading statements and/or failed to disclose that the materials submitted in support of the pimavanserin sNDA contained statistical and design deficiencies, that accordingly, the pimavanserin sNDA lacked the evidentiary support that the Company had led investors to believe it possessed, that the FDA was unlikely to approve the pimavanserin sNDA in its present form, and that as a result, the Company's public statements were materially false and misleading at all relevant times.

Those who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and should contact the Shareholders Foundation.

Contact:
Michael Daniels
Shareholders Foundation, Inc.
3111 Camino Del Rio North
Suite 423
San Diego, CA 92108
Tel: +1-(858)-779-1554
E-Mail: mail@shareholdersfoundation.com

About Shareholders Foundation, Inc.
The Shareholders Foundation, Inc. is a professional portfolio monitoring and settlement claim filing service, and an investor advocacy group, which does research related to shareholder issues and informs investors of securities lawsuits, settlements, judgments, and other legal related news to the stock/financial market. Shareholders Foundation, Inc. is in contact with a large number of shareholders and offers help, support, and assistance for every shareholder. The Shareholders Foundation, Inc. is not a law firm. Referenced cases, investigations, and/or settlements are not filed/initiated/reached and/or are not related to Shareholders Foundation. The information is provided as a public service. It is not intended as legal advice and should not be relied upon.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Investigation announced for Investors in ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) over potential Wrongdoing here

News-ID: 2356875 • Views:

More Releases from Shareholders Foundation

Investigation announced for Long-Term Investors in shares of West Pharmaceutical Services, Inc. (NYSE: WST) over potential Wrongdoing
Investigation announced for Long-Term Investors in shares of West Pharmaceutical …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of West Pharmaceutical Services, Inc.. Investors who are current long term investors in West Pharmaceutical Services, Inc. (NYSE: WST) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in (NYSE: WST stocks follows a lawsuit filed
Investigation announced for Long-Term Investors in Open Lending Corporation (NASDAQ: LPRO) over potential Wrongdoing
Investigation announced for Long-Term Investors in Open Lending Corporation (NAS …
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Open Lending Corporation. Investors who are current long term investors in Open Lending Corporation (NASDAQ: LPRO) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm for current long term investors in NASDAQ: LPRO stocks follows a lawsuit filed against Open
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings, Inc. (NYSE: BBAI)
Investigation announced for Long-Term Investors in shares in BigBear.ai Holdings …
An investigation on behalf of current long-term investors in shares of BigBear.ai Holdings, Inc. (NYSE: BBAI) concerning potential breaches of fiduciary duties by certain directors and officers of BigBear.ai Holdings, Inc. was announced. Investors who are current long term investors in BigBear.ai Holdings, Inc. (NYSE: BBAI) shares, have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, Inc. (NYSE: DV)
Lawsuit filed for Investors who lost money with shares of DoubleVerify Holdings, …
An investor, who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV), filed a lawsuit over alleged violations of Federal Securities Laws by DoubleVerify Holdings, Inc. in connection with certain allegedly false and misleading statements. Investors who purchased shares of DoubleVerify Holdings, Inc. (NYSE: DV) have certain options and for certain investors are short and strict deadlines running. Deadline: July 21, 2025. NYSE: DV investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com

All 5 Releases


More Releases for ACAD

Future Industry Growth Of Medical Thesis Writing Service Market Types and Applic …
"Worldwide Market Reports offers a 𝐔𝐩-𝐭𝐨 𝟕𝟎% 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 on Medical Thesis Writing Service Market Reports on Single User Access and Unlimited User Access" The latest research study released by Worldwide Market Reports on "Medical Thesis Writing Service Market 2025 Forecast to 2032" research provides accurate economic, global, and country-level predictions and analyses. It provides a comprehensive perspective of the competitive market as well as an in-depth supply chain analysis to assist
Deadline on June 18th coming up in Lawsuit for Investors in ACADIA Pharmaceutica …
A deadline is coming up on June 18, 2021 in the lawsuit filed for certain investors of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) over alleged securities laws violations by ACADIA Pharmaceuticals Inc. Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and there are strict and short deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD stockholders should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 -
Lawsuit filed for Investors in shares of ACADIA Pharmaceuticals Inc. (NASDAQ: AC …
An investor, who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), filed a lawsuit over alleged violations of Federal Securities Laws by ACADIA Pharmaceuticals Inc. Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) have certain options and for certain investors are short and strict deadlines running. Deadline: June 18, 2021. NASDAQ: ACAD investors should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. San Diego, CA based
Investigation announced for Investors in shares of ACADIA Pharmaceuticals Inc. ( …
ACADIA Pharmaceuticals Inc is under investigation over potential securities laws violations in connection with certain financial statements. Investors who purchased shares of ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), have certain options and should contact the Shareholders Foundation at mail@shareholdersfoundation.com or call +1(858) 779 - 1554. The investigation by a law firm focuses on whether a series of statements by ACADIA Pharmaceuticals Inc. regarding its business, its prospects and its operations were materially false
Business Etiquette Training Industry Market Detailed Insights on Upcoming Trends …
Business etiquette training, a key part of soft skills & communication, facilitated by MMM enlightens participants on the accepted behaviour patterns and manners key to their profession. It emphasis on a set of practices used and accepted in a multi-national work environment. It is designed for organizations that wish to ensure their employees are aware of workplace expectations and office manners. The class covers topics such as cubicle etiquette, email etiquette,
Milk Allergy Clinical Trials Review Market Outlook to 2023 – American College …
Oct 2018, New York USA (News)- Milk allergy is an adverse immune reaction to one or more proteins in cow's milk. When allergy symptoms occur, they can occur rapidly or have a gradual onset. The former may include anaphylaxis, a potentially life-threatening condition which requires treatment with epinephrine among other measures. The latter can take hours to days to appear, with symptoms including atopic dermatitis, inflammation of the esophagus, enteropathy